Diligence memo · auto-generated · as of July 2, 2026
Fractyl Laboratories Inc.
Fractyl Laboratories Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Fractyl Laboratories Inc. operates in Other Health Care, based in LEXINGTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Fractyl Laboratories Inc. has raised $290M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $100M on 2021-06-09.
Most recent recorded round closed around 2022-01-11.
Valuation (modeled)modeled
Provath models Fractyl Laboratories Inc. at approximately $310M (range $73M–$661M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.47× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 4.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 5.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 91% of those peers.
Closest niche peers: Gravie, Inc., EmpowerMe Holdings, LLC, Color Holdings, L.P., RSR Senior Residences, LLC, Gynesonics, Inc.
Peoplefiled
22 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.